A bare metal stent (BMS) for use in the superficial femoral artery (SFA) yields comparable safety and efficacy to drug-eluting stents at 12 months, according to data from a multinational trial ...
Caroline Lai was drawn to the 200-year-old building where Inn 422 in Lebanon County had operated for nearly a quarter century. Earlier this year the owner of several area Asian establishments and Bijo ...
Terumo has planned to release Misago RX in the U.S. Misago® is a peripheral self-expanding stent system consisting of a rapid exchange delivery catheter and a pre-mounted stent made of nitinol. The ...
SOMERSET, NJ (May 12, 2010) – Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced it has received an investigational device exemption (IDE) conditional approval ...
SOMERSET, N.J., Terumo Interventional Systems will introduce the MISAGO® RX Self-expanding Peripheral Stent to the U.S. market at the 2015 Society for Vascular Surgery Annual Meeting (SVS), June 17-20 ...
The FDA has approved the Misago Peripheral Stent System from Terumo to treat peripheral artery disease by restoring blood flow to the leg. Upon the FDA's disclosure Terumo almost immediately said it ...
The Misago stent is undergoing trials for approval in the U.S. and Japan--courtesy of Terumo Medical Terumo Medical completed enrollment in a safety and effectiveness study of its Misago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results